Your browser doesn't support javascript.
loading
Machine learning and patient-reported outcomes for longitudinal monitoring of disease progression in metastatic breast cancer: a multicenter, retrospective analysis.
Deutsch, Thomas M; Pfob, André; Brusniak, Katharina; Riedel, Fabian; Bauer, Armin; Dijkstra, Tjeerd; Engler, Tobias; Brucker, Sara Y; Hartkopf, Andreas D; Schneeweiss, Andreas; Sidey-Gibbons, Chris; Wallwiener, Markus.
Afiliación
  • Deutsch TM; Department of Obstetrics & Gynecology, Heidelberg University Hospital, Heidelberg, Germany.
  • Pfob A; Department of Obstetrics & Gynecology, Heidelberg University Hospital, Heidelberg, Germany; National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), Heidelberg, Germany; MD Anderson Center for INSPiRED Cancer Care (Integrated Systems for Patient-Reported Data), The Univers
  • Brusniak K; Florence-Nigthingale-Hospital, Department of Anaesthesiology and The Intensive Care Unit, Duesseldorf, Germany.
  • Riedel F; Department of Obstetrics & Gynecology, Heidelberg University Hospital, Heidelberg, Germany.
  • Bauer A; Insitute of Women's Health GmbH, Tübingen, Germany.
  • Dijkstra T; Insitute of Women's Health GmbH, Tübingen, Germany.
  • Engler T; Department of Women's Health, University of Tübingen, Tübingen, Germany.
  • Brucker SY; Department of Women's Health, University of Tübingen, Tübingen, Germany.
  • Hartkopf AD; Department of Women's Health, University of Ulm, Ulm, Germany.
  • Schneeweiss A; National Center for Tumor Diseases, University Hospital and German Cancer Research Center, Heidelberg, Germany.
  • Sidey-Gibbons C; MD Anderson Center for INSPiRED Cancer Care (Integrated Systems for Patient-Reported Data), The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Section of Paitent Centered Analytics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Wallwiener M; Department of Obstetrics & Gynecology, Heidelberg University Hospital, Heidelberg, Germany.
Eur J Cancer ; 188: 111-121, 2023 07.
Article en En | MEDLINE | ID: mdl-37229835
BACKGROUND: Assessments of health-related quality of life (HRQoL) play an important role in transition to palliative care for women with metastatic breast cancer. We developed machine learning (ML) algorithms to analyse longitudinal HRQoL data and identify patients who may benefit from palliative care due to disease progression. METHODS: We recruited patients from two institutions and administered the EuroQoL Visual Analog Scale (EQ-VAS) via an online platform over a 6-month period. We trained a regularised regression algorithm using 10-fold cross-validation to determine if a patient was at high or low risk of disease progression based on changes in the EQ-VAS scores using data of one institution and validated the performance on data of the other institution. Progression-free survival (PFS) was the end-point. We conducted Kaplan-Meier and Cox regression analysis adjusted for clinical risk factors. RESULTS: Of 179 patients, 98 (54.7%) had progressive disease after a median follow-up of 14weeks. Using EQ-VAS scores collected at weeks 1-6 to predict disease progression at week 12, in the validation set (n = 63), PFS was significantly lower in the intelligent EQ-VAS high-risk versus low-risk group: median PFS 7 versus 10weeks, log-rank P < 0.038). Intelligent EQ-VAS had the strongest association with PFS (adjusted hazard ratio 2.69, 95% confidence interval 1.17-6.18, P = 0.02). CONCLUSION: ML algorithms can analyse changes in longitudinal HRQoL data to identify patients with disease progression earlier than standard follow-up methods. Intelligent EQ-VAS scores were identified as independent prognostic factor. Future studies may validate these results to remotely monitor patients.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Calidad de Vida / Neoplasias de la Mama Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Female / Humans Idioma: En Revista: Eur J Cancer Año: 2023 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Calidad de Vida / Neoplasias de la Mama Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Female / Humans Idioma: En Revista: Eur J Cancer Año: 2023 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido